Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Share Options

16 Mar 2018 07:00

RNS Number : 9200H
Falanx Group Limited
16 March 2018
 

Falanx Group Limited

("Falanx" or "the Company")

Grant of Share Options

Falanx Group Ltd announces the grant of 15,000,000 share options to the Directors and 9,150,000 share options to other management and employees (together the "Share Options").

The Company considers it important to incentivise employees and Directors through share incentive arrangements and to align them with shareholders to create long term value.

Options under this plan are granted with a strike price of 5p each, this is approximately 11% higher than the mid-market closing price of 4.5p on 15 March 2018. The option scheme is structured so that there are only returns for participants where the share price has very significantly increased from the current levels. Individual Director grants are set out below:

Individual Director Option Grants

 

Current Share Options

New Grant

Enlarged Share Options

Mike Read

-

5,000,000

5,000,000

Ian Selby

-

5,000,000

5,000,000

John Blamire

500,000

4,500,000

5,000,000

Emma Shaw

750,000

500,000

1,250,000

 

Vesting Criteria

These options vest in three tranches: the first tranche when the share price reaches 7.5p (25%), the second tranche when the share price reaches 10p (25%) and the third tranche when the share price reaches 12.5p (50%). The Share Options only vest if the average share price has reached the relevant threshold level for a period of three months, save for the event of a change of control in the Company, in which case they will vest in full. Based on the mid-market closing price of 4.5p, there is no gain at all unless the share price increases by 66% and full gains are not achieved until a gain of 178% has been achieved.

A further option grant is planned soon for staff in the recently acquired First Base business.

Executive Directors are issued share options under the EMI Scheme and Non-Executive Directors and (any other ineligible participants) under an unapproved scheme, which has the same rules as the EMI Scheme but without the relevant tax concessions. The Share Options have an exercise period of 10 years from grant under the rules of the EMI Scheme.

The above grant of 24,150,000 options represents approximately 9% of the share capital following the admission of the shares announced on 6 March 2018.

   

 

Falanx Group Limited

Mike Read, Chairman and CEO

John Blamire, COO

Ian Selby, CFO

 

www.falanx.com

 

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis / James Keeshan

+44 (0) 203 368 3551

 

 

 

 

 

Turner Pope Investments (TPI) Ltd

Broker

Andy Thacker

 

IFC Advisory Ltd

Financial PR & IR

Graham Herring

Miles Nolan

Zach Cohen

+44 (0) 203 621 4120

 

 

 

+44 (0) 203 934 6630

     

 

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. The Group listed on AIM in June 2013 under ticker FLX For more information: http://www.falanx.com/ 

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Mike Read

2. Ian Selby

3. John Blamire

4. Emma Shaw

2

Reason for the notification

a)

Position/status

Directors and PDMRs of the Company

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Falanx Group Limited

b)

LEI

213800YO4F9CUQLALV19

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Options over Ordinary Shares

 

 

 

ISIN: VGG3338A1075

b)

Nature of the transaction

Grant of nil-cost options

 

c)

Price(s) and volume(s)

 

Price: 5p

Volume

1. 5,000,000

2. 5,000,000

3. 4,500,000

4. 500,000

 

5.

d)

Aggregated information

 

- volume: 15,000,000

- Price: 5p

e)

Date of the transaction

15 March 20018

f)

Place of the transaction

Not on a trading venue

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFKPDNNBKBKND
Date   Source Headline
18th Jan 20212:00 pmRNSPrice Monitoring Extension
13th Jan 20214:41 pmRNSSecond Price Monitoring Extn
13th Jan 20214:35 pmRNSPrice Monitoring Extension
13th Jan 20212:05 pmRNSSecond Price Monitoring Extn
13th Jan 20212:00 pmRNSPrice Monitoring Extension
13th Jan 202111:06 amRNSSecond Price Monitoring Extn
13th Jan 202111:00 amRNSPrice Monitoring Extension
13th Jan 20217:00 amRNSTriarii to include Microsoft Azure Sentinel
18th Dec 20207:00 amRNSUpdate on SolarWinds® Orion® Platform Cyberattack
17th Dec 20202:28 pmRNSResult of AGM
17th Dec 20207:00 amRNSInterim results
1st Dec 20207:00 amRNSTotal Voting Rights
23rd Nov 202010:12 amRNSNotice of AGM
4th Nov 20204:42 pmRNSDirector subscriptions/PDMR dealing and TVR
30th Oct 20204:17 pmRNSPublication of final results & total voting rights
30th Oct 20207:00 amRNSPreliminary results for year ended 31 March 2020
28th Oct 20207:00 amRNSFalanx joins SolarWinds TAP
2nd Oct 20201:53 pmRNSHolding(s) in Company
1st Oct 20202:28 pmRNSHolding(s) in Company
1st Oct 20202:21 pmRNSHolding(s) in Company
29th Sep 20207:00 amRNSConfirmation of successful fundraising
28th Sep 20204:55 pmRNSProposed Equity Fundraise
18th Sep 20207:00 amRNSStrategic Contract Win
21st Aug 202012:16 pmRNSDirector/PDMR Shareholding
17th Aug 20207:00 amRNSStrategic Contract Win
5th Aug 20207:00 amRNSTrading Statement
24th Jul 20207:00 amRNSHolding(s) in Company
24th Jul 20207:00 amRNSHolding(s) in Company
9th Jul 20202:19 pmRNSHolding(s) in Company
21st Apr 20207:00 amRNSSalary sacrifice, grant of options & PDMR dealing
27th Feb 202011:56 amRNSHolding(s) in Company
2nd Jan 20203:21 pmRNSDirector/PDMR Shareholding
20th Dec 20197:00 amRNSSale of Furnace and Directorate Change
3rd Dec 20194:40 pmRNSResult of AGM
3rd Dec 20197:00 amRNSInterim Results
22nd Nov 201910:18 amRNSHolding(s) in Company
11th Nov 20197:00 amRNSTrading update, notice of results & notice of AGM
25th Sep 20197:30 amRNSGrant of Share Options
25th Sep 20197:00 amRNSDirector/PDMR Shareholding
24th Sep 201911:37 amRNSDirector/PDMR Shareholding
23rd Sep 20193:13 pmRNSAvailability of report and accounts
19th Sep 20197:00 amRNSAnnual results for the year ended 31 March 2019
31st May 201911:39 amRNSDirector/PDMR Shareholding
29th May 20197:00 amRNSChange of Adviser
28th Mar 20197:00 amRNSDirectorate Change
22nd Mar 20197:00 amRNSChange of Adviser
18th Feb 201910:32 amRNSDirector / PDMR Shareholding
18th Feb 201910:18 amRNSDirector / PDMR Shareholding
21st Dec 20181:01 pmRNSGrant of Share Options
21st Dec 201812:47 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.